Outcomes, unmet needs, and challenges in the management of patients who withdraw from anti-CGRP monoclonal antibodies: A prospective cohort study
Although anti-CGRP/R mAbs have provided a substantial amelioration of migraine management, a relevant proportion of patients remains unresponsive and requires additional therapeutic support. Further research is required to identify non-responder features and address unmet needs in migraine treatment.
Authors
- Pierangelo Geppetti (ORCID: https://orcid.org/0000-0003-3797-8371)
- Bianca Raffaelli (ORCID: https://orcid.org/0000-0001-9758-1494)
- Alberto Chiarugi (ORCID: https://orcid.org/0000-0003-1022-2435)
- Marina Romozzi (ORCID: https://orcid.org/0000-0001-6016-3141)
- Alberto Boccalini
- Roberto De Icco (ORCID: https://orcid.org/0000-0001-9415-4948)
- Luigi Francesco Iannone (ORCID: https://orcid.org/0000-0003-3598-0195)
- Andrea Burgalassi (ORCID: https://orcid.org/0009-0001-7028-7735)
- Francesco De Cesaris (ORCID: https://orcid.org/0000-0003-0326-4485)
- Giulia Vigani (ORCID: https://orcid.org/0009-0000-0425-8170)
- Paolo Calabresi (ORCID: https://orcid.org/0000-0003-0326-5509)
Institutions
- Università Cattolica del Sacro Cuore (IT)
- University of Pavia (IT)
- Agostino Gemelli University Polyclinic (IT)
- Fondazione Istituto Neurologico Nazionale Casimiro Mondino (IT)
- Azienda Ospedaliero-Universitaria Careggi (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- University of Florence (IT)
- New York University (US)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Cephalalgia
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1177/03331024241273968
- Citations
- 8
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 3.08